822
Participants
Start Date
March 31, 2009
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
Aliskiren
Aliskiren 150 mg tablets taken orally daily. 1 tablet for the first two weeks followed by 2 tablets for 10 weeks.
Telmisartan
Telmisartan 40 mg capsules taken orally daily. 1 capsule the first 2 weeks followed by 2 capsules for 10 weeks.
Placebo to Aliskiren
Placebo to Aliskiren tablets taken orally daily. 1 Tablet for the first 2 weeks and 2 tablets during the no treatment (withdrawal) week.
Placebo to Telmisartan
Placebo to Telmisartan capsule taken orally daily. 1 capsule for the first 2 weeks and 2 capsules during the no treatment (withdrawal) week.
Investigative Site, Sorocaba
Investigative Site, Gatineau
Investigative Site, Guayaquil
Investigative Site, Erfurt
Invesitagtive Site, Budapest
Investigative Site, Kuala Lumpur
Investigative Site, Mexico City
Investigative Site, Panama City
Investigative Site, Manila
Investigative Site, Singapore
Investigative Site, Bratislava
Investigative Site, Cheongju-si
Investigative Site, Seville
Investigative Site, Istanbul
Investigative Site, Westbury
Investigative Site, Caracas
Lead Sponsor
Novartis
INDUSTRY